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ABSTRACT
Aims: To assess the prognostic correlates of Doppler
echocardiographically derived coronary flow reserve (CFR)
on two coronaries in patients with negative stress echo.
Vasodilator stress echocardiography allows dual imaging
of regional wall motion and CFR both on left anterior
descending (LAD) and right coronary artery (RCA).
Methods: The study group comprised 460 patients with
known or suspected coronary artery disease and negative
stress echo by wall motion criteria. All underwent
dipyridamole (up to 0.84 mg/kg over 6 minutes) stress
echo with CFR evaluation of either LAD or RCA by
Doppler, and were followed up for a median of
32 months. A CFR value of (2.0 was taken as abnormal.
Results: CFR was abnormal in 174 patients (38%) (57 in
LAD only, 48 in RCA only, and 69 in both LAD and RCA)
and normal in 286 patients (62%). During follow-up, there
were 77 cardiac events: 5 deaths, 44 acute coronary
syndromes (6 STEMI, and 38 NSTEMI) and 28 late
(.6 months from stress echo) revascularisations. CFR of
(2.0 on LAD was the strongest multivariable predictor of
either definite (death, acute coronary syndrome) and
major (death, acute coronary syndrome, late revascular-
isation) events, followed by diabetes mellitus. Anti-
ischaemic therapy at the time of testing and resting wall
motion abnormality were also independently associated
with major events. Preserved CFR in both LAD and RCA
was associated with better (p,0.0001) definite and
major event-free survival compared to abnormal CFR in
one or both coronary vessels.
Conclusion: CFR evaluation of either LAD or RCA allows
the identification of distinct prognostic patterns. In
particular, preserved CFR in both coronary vessels is
highly predictive of a very favourable outcome, while
reduced CFR in either coronary vessel, and especially on
LAD, is a strong predictor of future cardiac events.
Dual imaging of wall motion and coronary flow
reserve (CFR) during dipyridamole stress echocar-
diography has entered the echo laboratory as an
effective modality for both diagnostic and prog-
nostic purposes. In fact, CFR on left anterior
descending (LAD) or right coronary artery (RCA)
increases the accuracy of conventional wall motion
analysis to assess myocardial ischaemia.1–8
Moreover, CFR on LAD provides additional prog-
nostic value over stress echo result in patients with
known or suspected coronary artery disease
(CAD),9 10 and allows effective risk stratification
in different clinical settings, including diabetic
patients with unchanged wall motion contractility
during stress,11 patients with intermediate coron-
ary stenosis,12 patients with non-ischaemic
dilated13 14 and hypertrophic cardiomyopathy.15
Nevertheless, the prognostic information derived
by combined assessment of CFR on LAD and RCA
remains unknown.
This prospective, observational study was aimed
at investigating the prognostic correlates of CFR
assessed by transthoracic Doppler of both LAD and
RCA in patients with known or suspected CAD
and negative stress echo by wall motion criteria.
METHODS
Patients
From August 2003 to December 2006, 1104
patients underwent dipyridamole stress echocar-
diography at two Italian cardiology institutions
(Mestre and Cesena). In all, 497 patients had
inadequate imaging of flow Doppler on LAD
(n = 58, 5%) or RCA (n = 439, 40%) and were
excluded. Of 607 patients with dual imaging of
regional wall motion and CFR both on LAD and
RCA, 147 were excluded because of positive stress
echo for inducible ischaemia. The remaining 460
patients (260 men, 200 women; mean age 62 (SD
12) years) with negative stress echo by wall motion
criteria formed the study population. No patient
had significant valvular disease, congenital heart
disease or significant co-morbidity reducing life
expectancy to ,1 year. Follow-up data were
available for all subjects. The indication for stress
echocardiography was suspected CAD in 323 (70%)
and risk stratification of known CAD (that is,
history of myocardial infarction, coronary revascu-
larisation and/or angiographic evidence of >50%
diameter coronary stenosis) in 137 (30%) subjects.
Diabetes mellitus,16 arterial hypertension17 and
hypercholesterolaemia18 were defined according to
standard definitions. According to individual needs
and physicians’ choices, 266 (58%) patients were
evaluated after antianginal drugs had been discon-
tinued, and 194 (42%) patients were evaluated
during antianginal treatment (table 1). The study
was approved by the institutional review board. All
patients gave their written informed consent when
they underwent stress echocardiography. When
patients signed the written informed consent they
also authorised physicians to use their clinical data.
Stress echo data were collected and analysed by
stress echocardiographers not involved in patient
care.
Cardiac imaging and non-invasive testing
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Stress echocardiography
Transthoracic stress echocardiographic studies were performed
with a commercially available ultrasound machine (Sonos 5500–
7500 or IE 33, Philips Ultrasound, Andover, MA, USA) equipped
with a multifrequency phased-array sector scan probe (S3-S8 or
V3-V7) and with second harmonic technology. Two-dimen-
sional echocardiography and 12-lead electrocardiographic mon-
itoring were performed in combination with high-dose
dipyridamole (up to 0.84 mg over 6 minutes).19
Echocardiographic images were semiquantitatively assessed
using a 17 segments, four-point scale model of the left
ventricle.20 A wall motion score index was derived by dividing
the sum of individual segment scores by the number of
interpretable segments. Ischaemia was defined as stress-induced
new and/or worsening of pre-existing wall motion abnormality.
Resting wall motion abnormality was akinetic or dyskinetic
myocardium with no thickening during stress.
CFR was assessed during the standard stress echo examination
by an intermittent imaging of wall motion and both LAD20 and
RCA8 flow. Coronary flow in the mid-distal portion of LAD and
RCA was imaged, respectively, from the low parasternal long-axis
and a modified apical two-chamber view under the guidance of
colour Doppler flow mapping.1 In 162 (35%) patients with no
visualisation of colour-coded blood flow from the LAD or RCA at
baseline conditions, the procedure was attempted a second time
during contrast enhancement with Sonovue (Bracco-Byk-Gulden,
Konstanz, Germany) in bolus (0.5 ml intravenously).
All studies were digitally stored to simplify offline reviewing
and measurements. Coronary flow parameters were analysed
offline by use of the built-in calculation package of the ultrasound
unit. Flow velocities were measured at least twice for each study:
at baseline and at peak stress (before aminophylline injection). At
each time point, three optimal profiles of peak diastolic Doppler
flow velocities were measured, and the results were averaged. CFR
was defined as the ratio between hyperaemic peak and basal peak
diastolic coronary flow velocities. A CFR value of (2 was
considered abnormal. All observers were trained by the same
senior investigator (FR), who granted consistency in data
acquisition, storage and interpretation, through intensive joint
reading sessions. All investigators at the contributing centres
passed quality control criteria for regional wall motion and
Doppler interpretation before entering the study as previously
described.21 22 The previously assessed intra- observer and inter-
observer variability for measurements of Doppler recordings and
regional wall motion analysis assessment were ,10%.2
Follow-up data
Outcome was determined from patient interview at the out-
patient clinic, hospital chart reviews and telephone interviews
with the patient, his/her close relative or referring physician. The
clinical events recorded during the follow-up were death, non-
fatal acute coronary syndromes (ST-elevation myocardial infarc-
tion (STEMI), or non-ST-elevation myocardial infarction
(NSTEMI)), early (,6 months) and late (.6 months) coronary
revascularisation (surgery or angioplasty). In order to avoid
misclassification of the cause of death,23 overall mortality was
considered. STEMI was defined by typical symptoms, ST-
elevation on electrocardiogram and cardiac enzyme changes.
NSTEMI was an acute coronary syndrome causing typical chest
pain, cardiac enzyme elevation and/or electrocardiographic
modifications consistent with acute ischaemia24 requiring hospi-
talisation. Late revascularisation was considered as a clinical
endpoint, reflecting new or progressive symptoms. Follow-up
data were analysed for the prediction of definite events (death,
non-fatal acute coronary syndromes) and major events (death,
non-fatal acute coronary syndromes, late revascularisation).
Statistical analysis
Continuous variables are expressed as mean (SD). Continuous
variables were compared using the Student unpaired t test, while
differences of categorical variables were assessed by the x2 test.
The Kaplan-Meier curves were used for estimation of definite
event-free survival and major event-free survival. Patients under-
going coronary revascularisation within 6 months from testing
were censored at the time of the procedure. Annual event rates
were obtained from Kaplan-Meier estimates to take censoring of
the data into account. Only the first event was taken into
account. The association of selected variables with outcome was
assessed with the Cox’s proportional hazard model using
univariate and stepwise multivariate procedures. A significance
of 0.05 was required for a variable to be included in the
multivariate model, while 0.1 was the cut-off value for exclusion.
Hazard ratios (HR) with the corresponding 95% confidence
intervals (CI) were estimated. Moreover, clinical findings, stress
echo parameters and CFR were sequentially included in the
model. The global x2 value of the model was calculated from the
log likelihood ratio; a significant increase after the addition of
further variables indicated incremental prognostic value.
Statistical significance was set at p,0.05. The Statistical
Package for the Social Sciences (SPSS) was used for analysis.
RESULTS
Stress echocardiography
The main clinical and echocardiographic characteristics of the
study population are shown in table 1.
Table 1 Clinical and echocardiographic findings of the
study population
Age (years) 62 (12)
Males 260 (57%)
Clinical history
Prior myocardial infarction 105 (23%)
Prior CABG 20 (4%)
Prior PCI 75 (16%)
Left bundle branch block 35 (8%)
Family history of CAD 63 (14%)
Diabetes mellitus 84 (18%)
Arterial hypertension 276 (60%)
Hypercholesterolaemia 279 (61%)
Smoking habit 175 (38%)
Anti-ischaemic therapy at the time of test
b-Blockers 190 (41%)
Calcium antagonists 142 (31%)
Nitrates 83 (18%)
At least one medication 266 (58%)
Echocardiogram
EF 55 (7%)
Resting WMSI 1.13 (0.24)
Resting left ventricular ejection fraction 55 (7)
Resting WMA 142 (31%)
Mean CFR on LAD 2.41 (0.58)
Mean CFR on RCA 2.35 (0.49)
Data presented are mean value (SD) or number (%) of patients.
CABG, coronary artery bypass grafting; CAD, coronary artery
disease; CFR, coronary flow reserve; EF, ejection fraction; LAD, left
anterior descending artery; PCI, percutaneous coronary intervention;
RCA, right coronary artery; WMA, wall motion abnormality; WMSI,
wall motion score index.
Cardiac imaging and non-invasive testing
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No major complications occurred during the test. CFR was
abnormal in 174 patients (38%) (57 in LAD only, 48 in RCA
only and 69 in both LAD and RCA) and normal in 286 patients
(62%). Patients with abnormal CFR in one or both coronary
vessels were older (65 (11) vs 61 (13) years; p,0.0001), had
higher frequency of prior myocardial infarction (35% vs 15%;
p,0.0001), diabetes mellitus (25% vs 14%; p = 0.002), arterial
hypertension (71% vs 53%; p = 0.0001), hypercholesterolaemia
(71% vs 55%; p = 0.0006), higher resting WMSI (1.17 (0.28) vs
1.10 (0.21); p = 0.001) and underwent stress echo more
frequently while taking anti-ischaemic drugs (73% vs 49%;
p,0.0001) than those with preserved CFR in both LAD and
RCA. Hypercholesterolaemic patients had a significantly lower
CFR both in the LAD (2.30 (0.53) vs 2.56 (0.63); p,0.0001) and
RCA (2.26 (0.45) vs 2.49 (0.52); p,0.0001) compared to non-
hypercholesterolaemic patients.
Follow-up events
During a median follow-up of 32 months (first quartile 12, third
quartile 42), there were 77 cardiac events: 5 deaths, 44 non-fatal
acute coronary syndromes (6 STEMI, and 38 NSTEMI) and 28
late revascularisations (4 surgery, and 24 angioplasty). There
were 63 cardiac events in patients with reduced CFR in one or
both coronary vessels and 14 cardiac events in those with
normal CFR in both LAD and RCA (36% vs 5%; p,0.0001). In
addition, 42 patients underwent early revascularisation (9
surgery, and 33 angioplasty). Of these, 39 had reduced CFR in
Table 2 Univariate and multivariate indicators of definite events (death, myocardial infarction) and major events (death, myocardial infarction, late
revascularisation)
Definite events Major events
Univariate analysis Multivariate analysis Univariate analysis Multivariate analysis
HR (95% CI) p Value HR (95% CI) p Value HR (95% CI) p Value HR (95% CI) p Value
Age (years) 1.02 (1.00 to 1.05) 0.06 1.03 (1.01 to 1.05) 0.006
Gender (female) 1.52 (0.87 to 2.67) 0.15 1.08 (0.69 to 1.70) 0.73
Prior myocardial infarction 1.63 (0.88 to 3.04) 0.12 2.07 (1.29 to 3.33) 0.003
Prior CABG 2.09 (0.75 to 5.82) 0.16 1.99 (0.86 to 4.57) 0.11
Prior PCI 0.43 (0.16 to 1.21) 0.11 0.57 (0.27 to 1.18) 0.13
Left bundle branch block 0.94 (0.29 to 3.01) 0.91 0.97 (0.39 to 2.41) 0.96
Family history of CAD 1.28 (0.55 to 3.03) 0.58 1.18 (0.59 to 2.37) 0.64
Diabetes mellitus 2.01 (1.09 to 4.05) 0.03 1.97 (1.01 to 3.86) 0.05 2.63 (1.61 to 2.30) ,0.0001 2.22 (1.30 to 3.79) 0.003
Arterial hypertension 2.65 (1.38 to 5.10) 0.004 2.13 (1.29 to 3.51) 0.003
Hypercholesterolaemia 1.32 (0.74 to 2.36) 0.35 1.64 (1.01 to 2.67) 0.04
Smoking habit 0.73 (0.39 to 1.35) 0.31 1.06 (0.66 to 1.68) 0.82
Anti-ischaemic therapy
at the time of test 3.23 (1.61 to 6.47) 0.001 3.31 (1.80 to 5.44) ,0.0001 2.14 (1.13 to 4.03) 0.02
Resting WMSI 1.46 (0.51 to 4.21) 0.48 2.29 (1.10 to 4.76) 0.03
Resting EF 0.98 (0.95 to 1.02) 0.37 0.97 (0.94 to 0.99) 0.02
Resting WMA 1.62 (0.90 to 2.89) 0.11 2.31 (1.47 to 3.63) ,0.0001 3.43 (1.60 to 7.34) 0.001
CFR (2.0 on LAD 13.76 (7.15 to 26.48) ,0.0001 11.97 (5.49 to 26.11) ,0.0001 7.17 (4.48 to 11.46) ,0.0001 5.30 (2.91 to 9.63) ,0.0001
CFR (2.0 on RCA 4.68 (2.67 to 8.23) ,0.0001 4.68 (2. 98 to 7.37) ,0.0001
CI, confidence interval; HR, hazard ratio.
CABG, coronary artery bypass grafting; CAD, coronary artery disease; CFR, coronary flow reserve; EF, ejection fraction; LAD, left anterior descending artery; PCI, percutaneous
coronary intervention; RCA, right coronary artery; WMA, wall motion abnormality; WMSI, wall motion score index.
Figure 1 Definite event-free survival and major event-free survival according to the presence of preserved (2) or reduced (+) coronary flow reserve in
the left anterior descending (LAD) and the right coronary artery (RCA). Number of patients per year is shown.
Cardiac imaging and non-invasive testing
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one or both coronary vessels and 3 had normal CFR in both LAD
and RCA (22% vs 1%; p,0.0001).
Outcome prediction
The univariate and multivariate prognostic indicators of definite
and major events are listed in table 2. CFR of (2.0 on LAD was
the strongest multivariable predictor of both definite and major
events, followed by diabetes mellitus (table 2). Anti-ischaemic
therapy at the time of testing and resting wall motion
abnormality were also independently associated with major
events (table 2). The definite and major event-free survival was
markedly (p,0.0001) better for patients with preserved CFR in
both LAD and RCA than for those with abnormal CFR in one or
both coronary vessels (fig 1). When patients with wall motion
abnormalities were excluded from survival analysis, the same
dynamic of stratification was observed for definite event-free
survival (fig 2). Compared to patients with abnormal CFR in
LAD, those with abnormal CFR in both coronary vessels or in
RCA had higher definite event-free survival (p = 0.03 and
p = 0.008, respectively); the former showed also higher major
event-free survival (p = 0.04) (fig 1). Annual definite event-rate
according to the CFR result in the two vascular vessels is
reported in figure 3. At incremental analysis, CFR on LAD stress
echocardiography showed an incremental value versus clinical
evaluation and conventional stress echo parameters for the
prediction of both definite and major events (fig 4).
DISCUSSION
Dual imaging of wall motion and CFR on LAD is now the state-
of-the art technique for vasodilator stress echo, because of the
very high feasibility,2 3 11 and excellent diagnostic1–7 and prog-
nostic9–12 value compared to standard wall motion analysis.
Although it has suboptimal feasibility,1 CFR on RCA also
provides useful diagnostic information.1 8 However, the prog-
nostic effect of the combined assessment of CFR on LAD and
RCA has not been addressed previously. In the present study on
patients at relatively low risk, such as those with negative stress
echo by wall motion criteria, abnormal CFR on LAD was the
strongest independent predictor of future definite and major
events among clinical and echocardiographic parameters. This is
consistent with previously reported experiences in an unselected
cohort of patients,10 and in diabetic patients.11 The novel aspect
of the study was that the combination of CFR in both LAD and
RCA allowed the identification of distinct prognostic patterns.
In particular, a normal CFR in both coronary vessels was highly
predictive of a very favourable outcome, indicating absence of
either prognostically meaningful epicardial artery stenosis and/
or coronary microcirculation impairment. Explanations for
reduced CFR in the absence of stress-induced wall motion
Figure 2 Definite event-free survival and according to the presence of
preserved (2) or reduced (+) coronary flow reserve in the left anterior
descending (LAD) and the right coronary artery (RCA) in patients with no
resting wall motion abnormalities (RWMA). Number of patients per year
is shown.
Figure 3 Annual definite event rate in the study population separated in
the different subgroups according to coronary flow reserve (CFR) normal/
abnormal in the two vascular vessels— left anterior descending (LAD)
and posterior right coronary artery (RCA).
Figure 4 Global x2 value of significant
predictor modelling of definite and major
events according to an interactive
procedure. In the model CFR still added
significant information to clinical variables
and stress echocardiographic parameters.
Cardiac imaging and non-invasive testing
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abnormalities include mild-to-moderate epicardial coronary
artery stenosis,25 left ventricular hypertrophy,26 severe epicardial
coronary artery stenosis in the presence of anti-ischaemic
therapy27–30 and severe microvascular coronary disease in the
presence of patent epicardial coronary arteries.31–36 All these
conditions may adversely affect prognosis. In fact, a non-
ischaemic test under anti-ischaemic therapy was found to be
less prognostically benign in subjects with known or suspected
CAD,37 as well as in diabetic patients.38 Accordingly, anti-
ischaemic therapy at the time of testing was a multivariable
predictor of future major events in our study. Moreover, the
prognostic impact of microvascular coronary disease was
previously documented in several clinical settings.34 39–41
The assessment of CFR by Doppler echocardiography has
always been considered to be limited by the fact that it can be
assessed only in one vessel, excluding the other two that may
have a prognostic impact. There is a large body of evidence
suggesting that microvascular disease is not related to a single
vascular vessel, but when present, is the expression of a global
dysfunction.42 43 Nonetheless, the relative prognostic value of
one vessel over the other has never been assessed during Doppler
CFR suggesting that when the anterior and the posterior vessel
have an impaired CFR, it is likely that microvascular disease is
present. Our results have potential clinical implications. As a
negative stress echo with preserved CFR on LAD and RCA
confers a benign prognosis, no further investigation is required.
On the contrary, angiographic evaluation and/or aggressive
medical therapy can be considered, in spite of wall motion
negativity, for relatively higher-risk patients with reduced CFR
on either one, or both, LAD and RCA. From a practical
viewpoint, the assessment of CFR only on LAD is more feasible
and less technically demanding and its prognostic value remains
unchanged even after RCA assessment.
Study limitations
One the main limitations of Doppler echocardiographically
derived CFR on two coronary vessels is related to suboptimal
feasibility in the RCA vessel. Accordingly, we found 95%
feasibility for CFR on LAD and 60% for CFR on RCA. As test
feasibility is heavily affected by the skill of the operator and
advances in technology, it is likely that it may improve over
time. Contrast agents have not been employed in all cases,
which may have theoretically improved the feasibility on the
right coronary artery, because of costs and safety concerns. In
the present study, we adopted central core laboratory reading,
allowing us to minimise inter-operator variability.22
The Doppler technique needs a maximal vasodilation in order
to compare resting and peak diastolic velocities, whereas the
resting velocities may exert a prognostically significant meaning
only when measured in a quantitative way as happens with
positron emission tomography.44 Dipyridamole was the stressor
of choice because it allows the assessment of wall motion and
CFR in the same session. Its sensitivity is comparable to that of
dobutamine when high-dose protocols are employed.45
CONCLUSIONS
The present results add an important piece of information in
the stratification of patients at low risk, such as those with a
negative stress echo by wall motion criteria. Assessment of CFR
integrates and complements classic stress echocardiography
founded on regional wall motion analysis.7 46 With the addition
of CFR, measured in the anterior and posterior vessels, to wall
motion, the stress echocardiography response can be stratified
into a severity code mirroring the ischaemic cascade. On one
end of the spectrum, there is the totally normal pattern, with
hyperdynamic left ventricular function and preserved CFR both
on LAD and RCA, which is highly predictive of normal coronary
anatomy and normal physiological response of coronary micro-
circulation and macro-circulation. The CFR impairment on one
single vessel is more relevant when it occurs on the anterior one.
At the other end of the spectrum, the reduction of CFR on both
vessels identifies patients at risk of becoming ill in the long run.
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